- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/96 - Stabilising an enzyme by forming an adduct or a compositionForming enzyme conjugates
Patent holdings for IPC class C12N 9/96
Total number of patents in this class: 1695
10-year publication summary
|
166
|
161
|
137
|
152
|
113
|
88
|
79
|
59
|
60
|
34
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| aTyr Pharma, Inc. | 167 |
54 |
| President and Fellows of Harvard College | 6096 |
40 |
| Pangu BioPharma Limited | 106 |
38 |
| The Regents of the University of California | 20790 |
36 |
| Massachusetts Institute of Technology | 10259 |
35 |
| Novozymes A/S | 3383 |
30 |
| The Broad Institute, Inc. | 1979 |
30 |
| The General Hospital Corporation | 4870 |
22 |
| Regents of the University of Minnesota | 2792 |
21 |
| Life Technologies Corporation | 3458 |
18 |
| Amicus Therapeutics, Inc. | 354 |
17 |
| The Regents of the University of Colorado, a body corporate | 2812 |
17 |
| Yale University | 2550 |
17 |
| Toyota Motor Corporation | 35857 |
16 |
| Bioverativ Therapeutics Inc. | 211 |
16 |
| BASF SE | 21318 |
15 |
| New England BioLabs, Inc. | 505 |
15 |
| Comera Life Sciences, Inc. | 24 |
14 |
| BRANDEIS University | 340 |
13 |
| Chimera Bioengineering, Inc. | 45 |
13 |
| Other owners | 1218 |